Literature DB >> 16930163

Comorbidity between substance use disorders and psychiatric conditions.

Marc A Schuckit1.   

Abstract

AIM: To review information relevant to the question of whether substance-induced mental disorders exist and their implications. DESIGN AND
METHOD: This paper utilized a systematic review of manuscripts published in the English language since approximately 1970 dealing with comorbid psychiatric and substance use disorders.
FINDINGS: The results of any specific study depended on the definitions of comorbidity, the methods of operationalizing diagnostic criteria, the interview and protocol invoked several additional methodological issues. The results generally support the conclusion that substance use mental disorders exist, especially regarding stimulant or cannabinoid-induced psychoses, substance-induced mood disorders, as well as substance-induced anxiety conditions.
CONCLUSIONS: The material reviewed indicates that induced disorders are prevalent enough to contribute significantly to rates of comorbidity between substance use disorders and psychiatric conditions, and that their recognition has important treatment implications. The current literature review underscores the heterogeneous nature of comorbidity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930163     DOI: 10.1111/j.1360-0443.2006.01592.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  121 in total

Review 1.  Exercise-based treatments for substance use disorders: evidence, theory, and practicality.

Authors:  Sarah E Linke; Michael Ussher
Journal:  Am J Drug Alcohol Abuse       Date:  2014-11-14       Impact factor: 3.829

2.  Comorbidity among depression, conduct disorder, and drug use from adolescence to young adulthood: examining the role of violence exposures.

Authors:  Magdalena Cerdá; Melissa Tracy; Brisa N Sánchez; Sandro Galea
Journal:  J Trauma Stress       Date:  2011-12-06

Review 3.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

4.  Romantic relationship status changes and substance use among 18- to 20-year-olds.

Authors:  Charles B Fleming; Helene R White; Sabrina Oesterle; Kevin P Haggerty; Richard F Catalano
Journal:  J Stud Alcohol Drugs       Date:  2010-11       Impact factor: 2.582

5.  Prevalence of mental health disorders among low-income African American adolescents.

Authors:  Gayle R Byck; John Bolland; Danielle Dick; Alan W Ashbeck; Brian S Mustanski
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-02-06       Impact factor: 4.328

6.  Relationships among independent major depressions, alcohol use, and other substance use and related problems over 30 years in 397 families.

Authors:  Marc A Schuckit; Tom L Smith; Jelger Kalmijn
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

7.  Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders.

Authors:  Diane Warden; Katherine Sanchez; Tracy Greer; Thomas Carmody; Robrina Walker; Adriane Dela Cruz; Marisa Toups; Chad Rethorst; Madhukar H Trivedi
Journal:  Psychiatry Res       Date:  2016-09-15       Impact factor: 3.222

8.  Brief report: cognitive control helps explain comorbidity between alcohol use disorder and internalizing disorders.

Authors:  Jarrod M Ellingson; Leah S Richmond-Rakerd; Wendy S Slutske
Journal:  J Stud Alcohol Drugs       Date:  2015-01       Impact factor: 2.582

Review 9.  Genetic and environmental influences on psychiatric comorbidity: a systematic review.

Authors:  M Cerdá; A Sagdeo; J Johnson; S Galea
Journal:  J Affect Disord       Date:  2009-12-11       Impact factor: 4.839

Review 10.  Current status of co-occurring mood and substance use disorders: a new therapeutic target.

Authors:  Helen M Pettinati; Charles P O'Brien; William D Dundon
Journal:  Am J Psychiatry       Date:  2013-01       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.